Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals
- PMID: 21175263
- DOI: 10.3109/0284186X.2010.543144
Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals
Abstract
Background: Tamoxifen (TAM) is a nonsteroidal antiestrogen that has been widely used in the treatment of breast cancer through its anti-estrogen activity. Recent studies show that TAM is cytotoxic to both estrogen receptor (ER)-positive and ER-negative cells via the induction of apoptosis. However, the molecular mechanisms of this effect are not well understood. In the present study, we investigated the roles of c-Src, ERK, AKT and c-Cbl ubiquitin ligases during TAM-induced apoptosis of MCF-7 cells.
Material and methods: MCF-7 cell proliferation and apoptosis were measured by 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, and flow cytometry, respectively. c-Cbl expression, and the activity of c-Src, ERK, AKT were assayed by Western blotting. Overexpression of the wild and the dominant-negative type of c-Cbl (70Z/Cbl) were achieved by transient transfection of plasmids encoding c-Cbl and 70Z/Cbl, respectively, and were confirmed by Western blotting. Statistical analysis was performed using the t-test, and a p-value <0.05 was considered to be statistically significant.
Results: A high concentration of TAM (25 μM) induced a time-dependent apoptosis of MCF-7 cells. ERK1/2 and AKT were activated during TAM-induced apoptosis. The ERK1/2 inhibitor PD98059, the PI3K/Akt inhibitor LY294002, and the c-Src inhibitor PP2 all enhanced TAM action. Moreover, the ubiquitin ligase c-Cbl was up-regulated during this process. Over-expression of c-Cbl significantly enhanced the apoptosis-inducing effects of TAM, while 70Z/Cbl suppressed the apoptosis-inducing effects of TAM. Further investigation revealed that, overexpression of c-Cbl significantly downregulated the c-Src protein levels and TAM-induced AKT activity. But 70Z/Cbl significantly upregulated TAM-induced ERK and AKT activity.
Conclusions: This study demonstrates that c-Src, ERK, and AKT played a protective role during TAM-induced apoptosis, and that c-Cbl sensitized MCF-7 cells to TAM by modulating the expression of c-Src, and TAM-induced ERK and AKT activity.
Similar articles
-
Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.Oncol Rep. 2012 Jun;27(6):1879-86. doi: 10.3892/or.2012.1728. Epub 2012 Mar 15. Oncol Rep. 2012. PMID: 22427054
-
Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.Anticancer Res. 2009 Aug;29(8):3195-205. Anticancer Res. 2009. PMID: 19661335
-
Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity.Endocrinology. 2013 Jun;154(6):1990-8. doi: 10.1210/en.2013-1116. Epub 2013 Apr 1. Endocrinology. 2013. PMID: 23546601
-
Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens.Biochem Cell Biol. 1994 Nov-Dec;72(11-12):537-45. doi: 10.1139/o94-072. Biochem Cell Biol. 1994. PMID: 7654327 Review.
-
Delineating the molecular mechanisms of tamoxifen's oncolytic actions in estrogen receptor-negative cancers.Eur J Pharmacol. 2016 Jun 15;781:173-80. doi: 10.1016/j.ejphar.2016.04.017. Epub 2016 Apr 12. Eur J Pharmacol. 2016. PMID: 27083550 Review.
Cited by
-
E3 Ubiquitin Ligase in Anticancer Drugdsla Resistance: Recent Advances and Future Potential.Front Pharmacol. 2021 Apr 15;12:645864. doi: 10.3389/fphar.2021.645864. eCollection 2021. Front Pharmacol. 2021. PMID: 33935743 Free PMC article. Review.
-
The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies.Front Pharmacol. 2024 Jul 26;15:1432545. doi: 10.3389/fphar.2024.1432545. eCollection 2024. Front Pharmacol. 2024. PMID: 39130630 Free PMC article. Review.
-
The role of E3 ubiquitin ligase Cbl proteins in interleukin-2-induced Jurkat T-cell activation.Biomed Res Int. 2013;2013:430861. doi: 10.1155/2013/430861. Epub 2013 Mar 27. Biomed Res Int. 2013. PMID: 23586039 Free PMC article.
-
The crosstalk between ubiquitination and endocrine therapy.J Mol Med (Berl). 2023 May;101(5):461-486. doi: 10.1007/s00109-023-02300-z. Epub 2023 Mar 24. J Mol Med (Berl). 2023. PMID: 36961537 Review.
-
Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells.EMBO Mol Med. 2013 May;5(5):723-36. doi: 10.1002/emmm.201202140. Epub 2013 Apr 22. EMBO Mol Med. 2013. PMID: 23606532 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous